Glaucoma is an eye condition caused by fluid deposits behind the eye. This may damage the optic nerve, which can lead to visual field loss and blindness. Open-angle glaucoma is the most prevalent type of glaucoma. A blockage causes it in a special membrane (trabecular meshwork), preventing the aqueous humor from draining out properly.
It is the second biggest cause of blindness after cataracts worldwide. It is also the leading cause of vision loss in people over 60.
Unfortunately, glaucoma has no cure. But effective treatment can prevent it from further damaging your eyes.
So continue reading to learn more!
More About the New Treatment for Glaucoma
On 26th September 2022, Omlononti became the latest glaucoma treatment approved by FDA. Omlonti is the latest eye drop for glaucoma and ocular hypertension.
Omlonti is the first in a drug class called relatively selective prostaglandin EP2 receptor agonists. It reduces excess pressure in the eye by increasing the drainage of a liquid called aqueous humor.
The standard dosage is one drop in the affected eye once daily in the evening.
What are its Side Effects?
Every treatment has adverse effects. No matter how meager one should know them!
We have mentioned them below!
The following are some of the known side effects of this latest eye drop for glaucoma:
Several other factors should be considered before considering this new glaucoma treatment.
We have discussed them in detail. So make sure you take advantage of it!
What Should You Know Before Considering this New Glaucoma Treatment?
The following are some of the points you should remember before opting for this latest glaucoma treatment:
References:
https://www.visionmonday.com/eyecare/ophthalmology
https://my.clevelandclinic.org/health/diseases/4212-glaucoma
